Evidence map›Paper›PMID 33193397›Full record

ReviewFrontiers in immunology2020

How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-

Benoît Vandenhove, Lorenzo Canti, Hélène Schoemans, Yves Beguin, Frédéric Baron, Carlos Graux, Tessa Kerre, Sophie Servais

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Radiology. Imaging cancer · 2025
    Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Benoît VandenhoveLaboratory of Hematology, GIGA-I3, GIGA Institute, University of Liège, Liège, Belgium.
Lorenzo CantiLaboratory of Hematology, GIGA-I3, GIGA Institute, University of Liège, Liège, Belgium.
Hélène SchoemansDepartment of Clinical Hematology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Yves BeguinLaboratory of Hematology, GIGA-I3, GIGA Institute, University of Liège, Liège, Belgium.
Frédéric BaronLaboratory of Hematology, GIGA-I3, GIGA Institute, University of Liège, Liège, Belgium.
Carlos GrauxDepartment of Clinical Hematology, CHU UCL Namur (Godinne), Université Catholique de Louvain, Yvoir, Belgium.
Tessa KerreHematology Department, Ghent University Hospital, Ghent University, Ghent, Belgium.
Sophie ServaisLaboratory of Hematology, GIGA-I3, GIGA Institute, University of Liège, Liège, Belgium.
University of Liège · BECentre Hospitalier Universitaire de Liège · BEGhent University Hospital · BEKU Leuven · BEUCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immunotherapy against hematological cancers for more than six decades. Its therapeutic efficacy relies on the cytoreductive effects of the conditioning regimen but also on potent graft-

Indexed as

AnimalsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansTransplantation, Homologousacute graft-versus-host diseaseallogeneic stem cell transplantationalloreactivityimmune toleranceT cellstissue tolerance

Identifiers

PMID33193397
PMCPMC7609863
OpenAlexW3094368990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.